Blueshift Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,179
| Closed | -$249K | – | 597 |
|
|
2025
Q1 | $249K | Sell |
16,179
-2,189
| -12% | -$33.6K | 0.1% | 307 |
|
|
2024
Q4 | $405K | Sell |
18,368
-22,718
| -55% | -$501K | 0.15% | 196 |
|
|
2024
Q3 | $740K | Buy |
+41,086
| New | +$740K | 0.18% | 138 |
|
|
2024
Q1 | – | Sell |
-22,987
| Closed | -$240K | – | 370 |
|
|
2023
Q4 | $240K | Buy |
+22,987
| New | +$240K | 0.13% | 212 |
|
|
2023
Q3 | – | Sell |
-51,585
| Closed | -$388K | – | 421 |
|
|
2023
Q2 | $388K | Buy |
51,585
+19,740
| +62% | +$149K | 0.15% | 169 |
|
|
2023
Q1 | $282K | Buy |
+31,845
| New | +$282K | 0.12% | 233 |
|
|
2022
Q4 | – | Sell |
-14,699
| Closed | -$119K | – | 632 |
|
|
2022
Q3 | $119K | Sell |
14,699
-54,986
| -79% | -$445K | 0.03% | 545 |
|
|
2022
Q2 | $524K | Sell |
69,685
-21,661
| -24% | -$163K | 0.09% | 318 |
|
|
2022
Q1 | $858K | Sell |
91,346
-180,906
| -66% | -$1.7M | 0.08% | 305 |
|
|
2021
Q4 | $2.18M | Buy |
+272,252
| New | +$2.18M | 0.19% | 141 |
|
|
2021
Q3 | – | Sell |
-66,936
| Closed | -$663K | – | 1294 |
|
|
2021
Q2 | $663K | Buy |
+66,936
| New | +$663K | 0.04% | 469 |
|